Pictured: Nai-Kong Cheung & Jeremy D
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, January 9, 2014

Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.

Pictured: Jedd Wolchok & Alexander Rudensky
Announcement
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 6, 2014

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.

Pictured: Stem cell-derived nerve cells exposed to progerin
In the Lab
By Jennifer Bell, PhD  |  Monday, December 30, 2013

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: T cells
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 23, 2013

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

In Memoriam
By Craig Thompson, MD, President and CEO  |  Friday, December 20, 2013

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.

Pictured: Alexander Rudensky
Profile
By Celia Gittelson, BA  |  Monday, December 16, 2013

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the News
By Christina Pernambuco-Holsten, MA  |  Friday, December 6, 2013

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Pictured: Michael Foley
Announcement
By Memorial Sloan Kettering  |  Thursday, December 5, 2013

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

Pictured: Casper zebrafish
Snapshot
By Jennifer Bell, PhD  |  Tuesday, December 3, 2013

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

Pictured: Joan Massagué
Announcement
By Celia Gittelson, BA  |  Monday, November 25, 2013

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Center News

Stay Informed

Get the latest information about cancer care and research every month.